- Location
1
result for "
steady absorption
"-
Nova Laboratories : European Commission Approved of Its New Xaluprine Oral for Formulation
Dec 10, 2012Nova Laboratories has announced the European Commission approval of new Xaluprine oral formulation without the preservative propyl parabens. Supplied from January 2013, revised formulation is indicated for acute lymphoblastic leukaemia ...
Tags: European Commission, new Xaluprine oral formulation, steady absorption
